PRESS RELEASE published on 10/11/2023 at 06:55, 1 year 1 month ago Leclanché SA Supply Battery System for Hybrid Retrofit of Lafarge River Tug
PRESS RELEASE published on 10/02/2023 at 06:55, 1 year 1 month ago Leclanché SA announces extension of the publication deadline for the 2023 interim results
PRESS RELEASE published on 09/27/2023 at 20:15, 1 year 1 month ago Leclanché SA: Brunvoll Picks Leclanché to Provide Battery Storage System for Norwegian Ferry
PRESS RELEASE published on 09/13/2023 at 19:00, 1 year 2 months ago Leclanché SA: Leclanché Selected to Supply Battery Systems for a Second Pair of CMAL Hybrid Ferries Serving Scotland’s Outer Hebrides Islands
Published on 11/22/2024 at 23:55, 10 hours 37 minutes ago Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 11 hours 2 minutes ago Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 11 hours 27 minutes ago Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 12 hours 2 minutes ago Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.
Published on 11/22/2024 at 18:14, 16 hours 18 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 17:53, 16 hours 39 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 17 hours 37 minutes ago EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 18 hours 32 minutes ago Proposed cancellation of admission to trading
Published on 11/21/2024 at 06:58, 2 days 3 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 2 days 15 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 2 days 16 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 2 days 16 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
